Royal Bank of Canada restated their outperform rating on shares of Acadia Healthcare (NASDAQ:ACHC – Free Report) in a report issued on Friday morning, Benzinga reports. The firm currently has a $94.00 price objective on the stock.
Other research analysts have also issued research reports about the company. Cantor Fitzgerald restated a neutral rating and issued a $90.00 target price on shares of Acadia Healthcare in a report on Monday, August 19th. Barclays dropped their target price on Acadia Healthcare from $89.00 to $83.00 and set an overweight rating on the stock in a report on Thursday, August 1st. Finally, Deutsche Bank Aktiengesellschaft raised their target price on Acadia Healthcare from $70.00 to $75.00 and gave the company a hold rating in a report on Friday, August 2nd. One research analyst has rated the stock with a sell rating, three have given a hold rating and six have issued a buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of Moderate Buy and a consensus price target of $87.44.
Read Our Latest Report on ACHC
Acadia Healthcare Stock Down 0.3 %
Acadia Healthcare (NASDAQ:ACHC – Get Free Report) last announced its quarterly earnings results on Wednesday, July 31st. The company reported $0.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.87 by $0.04. The business had revenue of $796.00 million for the quarter, compared to analyst estimates of $784.38 million. Acadia Healthcare had a positive return on equity of 11.42% and a negative net margin of 0.17%. The company’s quarterly revenue was up 8.8% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.92 earnings per share. As a group, research analysts forecast that Acadia Healthcare will post 3.51 EPS for the current fiscal year.
Institutional Trading of Acadia Healthcare
A number of large investors have recently bought and sold shares of the company. Vanguard Group Inc. increased its position in Acadia Healthcare by 0.3% in the fourth quarter. Vanguard Group Inc. now owns 8,861,427 shares of the company’s stock worth $689,065,000 after buying an additional 30,296 shares during the last quarter. William Blair Investment Management LLC increased its position in Acadia Healthcare by 20.7% in the second quarter. William Blair Investment Management LLC now owns 3,515,464 shares of the company’s stock worth $237,434,000 after buying an additional 604,070 shares during the last quarter. Point72 Asset Management L.P. increased its position in Acadia Healthcare by 266.0% in the second quarter. Point72 Asset Management L.P. now owns 2,270,340 shares of the company’s stock worth $153,339,000 after buying an additional 1,650,040 shares during the last quarter. Bank of New York Mellon Corp increased its position in Acadia Healthcare by 6.6% in the second quarter. Bank of New York Mellon Corp now owns 1,249,369 shares of the company’s stock worth $84,382,000 after buying an additional 77,509 shares during the last quarter. Finally, Avidity Partners Management LP increased its position in Acadia Healthcare by 61.8% in the fourth quarter. Avidity Partners Management LP now owns 1,156,692 shares of the company’s stock worth $89,944,000 after buying an additional 441,692 shares during the last quarter.
Acadia Healthcare Company Profile
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
See Also
- Five stocks we like better than Acadia Healthcare
- Top Biotech Stocks: Exploring Innovation Opportunities
- The Average 401k Balance by Age Explained
- How to Calculate Options Profits
- 3 Uranium Stocks To Gain as Microsoft Goes Nuclear to Power AI
- What Does Downgrade Mean in Investing?
- Biotech Boom Ahead? Key Stocks and ETFs to Watch Now
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.